Skip to main content
. Author manuscript; available in PMC: 2018 May 14.
Published in final edited form as: Mol Genet Metab. 2017 Apr 26;122(1-2):126–134. doi: 10.1016/j.ymgme.2017.04.010

Figure 3. Mean Adjusted Plasma Concentration-Time Profiles.

Figure 3

Mean (± SD) plasma concentrations of ManNAc (A) and Neu5Ac (B) after a single oral dose of ManNAc administered to fasted GNE myopathy subjects with baseline adjustment. Baseline adjustment was made by subtracting ManNAc or Neu5Ac concentration at time t=0 h for each subject.